简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-08-18 11:55 The Health Bank to Partner with Nanotronics Health, LLC, to Distribute Low-Cost, US-Manufactured Non-Invasive Ventilator for Respiratory Support During COVID-19 Pandemic
2020-08-18 09:48 LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions
2020-08-17 14:26 Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research
2020-08-14 15:56 DeltaTrak Enhances Its Cold Chain Restart Program to Help Customers Battle COVID-19
2020-08-13 09:56 Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease
2020-08-11 19:04 Blackrock Microsystems Licenses Wyss Center’s Real-time Neural Signal Processing Platform
2020-08-11 19:02 FINEOS Acquires Limelight Health
2020-08-11 10:11 Five of Kirin’s Proprietary Lactococcus lactis strain Plasma Products Registered as “Foods with Function Claims”
2020-08-10 13:24 Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
2020-08-07 14:52 Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening
2020-08-07 09:45 Crown Bioscience Signals Increased Investment in Digital Transformation with Appointment of New COO
2020-08-06 13:30 Vifor Pharma Group Reports Continued Growth in H1 2020
2020-08-05 12:47 JEOL: Release of the New Scanning Electron Microscope JSM-IT700HR
2020-08-05 12:44 Smiths Detection Completes Acquisition of PathSensors
2020-08-04 16:12 Patient Safety Movement Foundation, the American Society of Anesthesiologists, The Leapfrog Group, and the International Society for Quality in Health Care Join Forces for #UniteForSafeCare World Patient Safety Day Campaign
2020-08-03 18:34 Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum
2020-08-03 13:05 Terns Pharmaceuticals Announces Completion and Positive Results from Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH
2020-07-31 17:41 Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
2020-07-30 19:30 Empagliflozin meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in Phase III trial in adults with and without diabetes
2020-07-30 09:39 Esri and United Nations Create COVID-19 Population Vulnerability Dashboard